director of member services at the Massachusetts Hospital Association.
Harry Atkins, CSAP, ASAP’s treasurer and member of the executive committee, is now senior director, corporate development, at Dr. Reddy’s Laboratories in Bridgewater, NJ. Jay Chitnis, CA-AM, president of ASAP’s California Chapter, is now director, business development and alliances, at Isilon Systems, an EMC company.
2011 ASAP BioPharma Conferences Realizing Value Through Effective Alliance Management May 31-June 1, Basel, Switzerland June 1-2, New Brunswick, N.J. USA 2012 ASAP Global Summit Mastering the Art and Science of Alliance March 5-8, 2012 Caesars Palace, Las Vegas, Nev., US To register for these events, visit www.strategic-alliances.org
Alliance News Quintiles Supports Samsung’s Entry into Biopharma Market Through Joint Venture
Samsung Electronics Co., Ltd., the world’s largest electronics company, and its affiliated companies have entered into a strategic partnership with Quintiles, the world’s leading pharmaceutical services company, to support Samsung’s entry into the biopharmaceuticals market, Quintiles announced recently. Under an agreement signed in February, Quintiles will make a minority 10 percent investment of approximately $30 million USD to start a new joint venture company with Samsung in the first half of 2011 to provide biopharmaceutical contract manufacturing services in South Korea. Samsung will own the remaining 90 percent of the joint venture company. The strategic partnership will support Quarter 2, 2011
Samsung’s entry into the biopharmaceutical market and reinforces Quintiles’ role as an ally to help companies succeed in the new health landscape. http://www.quintiles.com/news/2011-228/quintiles-samsungs-biopharma-jointventure/
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Eli Lilly and Company and Boehringer Ingelheim have announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim’s two oral diabetes agents— linagliptin and BI10773—as well as Lilly’s two basal insulin analogues—LY2605541 and LY2963016—and the option to co-develop and co-commercialize Lilly’s anti-TGF-beta monoclonal antibody. This major diabetes care agreement centers on four pipeline compounds representing several of the largest and most promising product classes. Boehringer Ingelheim’s innovative late-stage diabetes pipeline drives its expansion into a new therapeutic area, supplemented by two basal insulin analogues, currently under development from Lilly. The agreement also furthers Lilly’s commitment to offer one of the broadest portfolios in diabetes care and provide together with Boehringer more options for people with diabetes, their health care providers and payers. http://newsroom.lilly.com/releasedetail. cfm?ReleaseID=542971
Juniper Networks Partner Conference Celebrates Success, Looks to the Future of the New Network In April, Juniper Networks welcomed more than 700 channel partners to its 2011 Americas Partner Conference at the Arizona Biltmore Hotel in Phoenix, as well as virtually via webcast.
This annual event featured keynotes from Juniper Networks executives CEO Kevin Johnson, CMO Lauren Flaherty, CFO Robyn Denholm, and Senior Vice President of Worldwide Partners Emilio Umeoka. Themed “It’s Time to Build a New Network,” the event offered Juniper Networks’ partners throughout the Americas the opportunity to engage face-to-face with Juniper executives and other partners about the growing business value of the new network, and to discuss how to capitalize on the megatrends affecting the IT industry. The annual conference also celebrated the mutual growth and success of Juniper Networks and its Americas partner community, and offered a closer look at the global and regional strategies, disruptive innovation, service specializations, and go-to-market initiatives that further differentiate Juniper Networks and its partners. “Juniper Networks’ Americas partner community thrived in 2010, with our top-performing partners posting double-digit, year-over-year growth and earning a record-setting number of service and technology specializations,” said Frank Vitagliano, senior vice president, Partners-Americas, Juniper Networks. “Throughout 2011, Juniper Networks’ vision of ‘Innovative Partnering’ will empower our partners to be disruptively innovative, valued, and more profitable selling Juniper Networks,” Vitagliano said. “With the recent expansion of our portfolio and new service specializations, Juniper Networks Partners are primed to not only grow their businesses, but lead the industry in building the new network. It’s our time and together with our partners we are accelerating the global adoption of the new network.” http://www.juniper.net/us/en/company/press-center/press-releases/2011/ pr_2011_04_11-08_00.html 17
The magazine of the Association of Strategic Alliance Professionals